Faculty of Medicine and Health Sciences, Department of Medicine, University of Antwerp, Antwerp, Belgium.
Department of Pathology, University Hospital of Antwerp, Antwerp, Belgium.
J Clin Pathol. 2020 Jan;73(1):1-6. doi: 10.1136/jclinpath-2019-205864. Epub 2019 Jul 15.
Traditionally, immunohistochemistry (IHC) is used by pathologists to localise specific proteins or peptides in tissue slides. In the era of personalised medicine, however, molecular tissue analysis becomes indispensable for correct diagnosis, prognosis and therapeutic decision, not only on the DNA or mRNA level but also on the protein level. Combining molecular information with imaging presents many advantages. Therefore, matrix-assisted laser desorption/ionisation imaging mass spectrometry (MALDI IMS) is a promising technique to be added to the armamentarium of the pathologist. Here, we focus on the workflow, advantages and drawbacks of both MALDI IMS and IHC. We also briefly discuss a few other protein imaging modalities and give examples of applications.
传统上,病理学家使用免疫组织化学(IHC)在组织切片中定位特定的蛋白质或肽。然而,在个性化医疗时代,分子组织分析对于正确诊断、预后和治疗决策变得不可或缺,不仅在 DNA 或 mRNA 水平上,而且在蛋白质水平上也是如此。将分子信息与成像相结合具有许多优势。因此,基质辅助激光解吸/电离成像质谱(MALDI IMS)是病理学家可以选择的一种很有前途的技术。在这里,我们重点介绍 MALDI IMS 和 IHC 的工作流程、优点和缺点。我们还简要讨论了其他几种蛋白质成像模式,并举例说明了它们的应用。